Help us: Donate
Follow us on:
×

Menu

Back

Tag: Policy

Debate
A significant debate has originated regarding the inclusion of MG2A, a code for old age, in the ICD-11 for Mortality and Morbidity Statistics. What is the ICD-11? The 11th revision of the International Classification of Diseases, which goes into effect this month, is managed by the World Health Organization. Its stated purpose is twofold: allows...
AL4I Panel
A recent online discussion panel revealed some valuable insights into the political aspects of increasing healthy human lifespans. Perhaps the most exciting part of the panel involves the idea that getting politicians to support longevity/aging therapeutics might not be as hard as people may think. Giving our field an effective political voice On December 9th,...
EARD2021 Tina Woods
At Ending Age-Related Diseases 2021, Elena Milova of Lifespan.io interviewed Tina Woods on the development of a longevity ecosystem, the importance of language, and the social aspects of extending lifespans. Script Elena: Greetings to the participants of Ending Age-Related Diseases 2021. This conference brings together thought leaders and researchers working on rejuvenation biotechnology with the...
Dylan Livingston Interview
Dylan Livingston is the founder and president of A4LI – the Alliance for Longevity Initiatives. This newly created organization aims to fill an important niche as a non-profit that would educate American politicians on life extension and promote policy changes beneficial for our cause. How can this be done, especially in the current age of...
Aubrey de Grey EARD2021
At our fourth annual Ending Age-Related Diseases conference, Dr. Aubrey de Grey discusses the transition of rejuvenation biotechnology from proof-of-concept to companies engaging in clinical trials, and he outlines the challenges inherent in such a move. Script It's great to be here, of course. I just thought I'd start by saying that some of you...
Aging timeline
Using Peter Pan, Wolverine, and a powerful economic model, a trio of prominent scientists argues that slowing aging can bring gargantuan economic benefits – an order of magnitude bigger than previously thought [1]. The marriage of economics and geroscience The paper, published in Nature Aging, looks rather unusual. It is co-authored by one of the...